HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

Nature Medicine

Volumn 3, Issue 5, 1997, Pages 533-540

  Connors, Mark ^a   Kovacs, Joseph A ^a   Krevat, Seth ^a   Gea Banacloche, Juan C ^a,b   Sneller, Michael C ^a   Flanigan, Mark ^a   Metcalf, Julia A ^a   Walker, Robert E ^a   Falloon, Judith ^a   Baseler, Michael ^c   Stevens, Randy ^c   Feuerstein, Irwin ^a   Masur, Henry ^a   Clifford Lane, H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INDINAVIR; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEINASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 16944367032     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0597-533     Document Type: Article

References (21)

1. Lane, H.C. et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 313, 79-84 (1985).
2. Miedema, F. et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men: HIV affects the immune system before CD4* T cell depletion occurs. J. Clin. Invest. 82, 1908-1914 (1988).
3. Clerici, M. et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84, 1892-1899 (1989).
4. Lucey, D.R. et al. Human immunodeficiency virus infection in the US Air Force: Seroconversions, clinical staging and assessment of T helper cell functional assay to predict change in CD4* T cell counts. J. Infect. Dis. 164, 631-637 (1991).
5. Gray, D. Immunological memory. Annu. Rev. Immunol. 11, 49-77 (1993).
6. Zinkernagel, R.M. The role of antigen in maintaining T cell memory. Dev Biol. Stand. 82, 189-191 (1994).
7. Sanders, M.E. et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J. Immunol. 140, 1401-1407 (1988).
8. Salmon, M., Kitas, G.D. & Bacon, P.A. Production of lymphokine mRNA by CD45R* and CD45R- helper T cells from human peripheral blood and by human CD4* T cell clones. J. Immunol. 143, 907-912 (1989).
9. Sprent, J. & Tough, D.F. Lymphocyte life-span and memory. Science 265, 1395-1400 (1994).
10. Tough, D.F. & Sprent, J. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179, 1127-1135 (1994).
11. Beverley, P.C. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin. Immunol. 4, 35-41 (1992).
12. Mclean, A.R. & Michie, C.A. In vivo estimates of division and death rates of human T lymphocytes. Proc. Natl. Acad. Sci. USA 92, 3707-3711 (1995).
13. Trowbridge, I.S. & Thomas, M.L. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12, 85-116 (1994).
14. Sprent, J. Lifespans of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5, 433-138 (1993).
15. Mackall, C.L. et al. Age, thymopoiesis, and CD4* T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332, 143-149 (1995).
16. Steis, R.G. et al. Kinetics of recovery of CD4* T cells in peripheral blood of deoxycoformycin-treated patients. J. Natl. Cancer Inst. 83, 1678-1679 (1991).
17. Puisieux, I. et al. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153, 2807-2818 (1994).
18. Gulwani-Akolkar, B. et al. T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J. Exp. Med. 174, 1139-1146 (1991).
19. β T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180, 861-872 (1994).
20. Cochet, M. et al. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen, Eur. J. Immunol. 22, 2639-2647 (1992).
21. Kovacs, J.A. et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335, 1350-1356 (1996).